Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645827 · ClinicalTrials.gov registry record · NA
Use of an Insulin Infusion Conversion Equation (IICE) to Control Blood Glucose in Hospitalized Patients
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT00645827 is a NA study that has completed, run by Emory University. The registered enrollment target is 78 participants.
The verdict
NCT00645827, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Insulin infusions are commonly used in hospitalized diabetics to control blood sugar, and they are effective. However, insulin infusions require the use of limited resources. Insulin infusions are therefore changed to insulin shots as a patient recovers. Once an insulin infusion is stopped and shots are started, blood sugar control is harder to maintain. This is, in part, because physicians have different ideas on how to dose insulin shots in hospitalized patients. A math equation has been developed by the research staff that attempts to predict the effective doses of insulin shots in patients whose insulin infusion have just been stopped. The math equation was developed for patients with type 2 diabetes mellitus. In this study, all patients will be treated with the same type of insulin shots, with doses of the insulin shots chosen either by the math equation or by the judgment of the patient's physician. The study will then follow blood sugar values for 24 hours to see if the math equation is effective. If the equation is proven to be effective, a new tool will exist for physicians to determine the best dose of insulin shots for type 2 diabetics. Such a tool would, in turn, allow for widespread use of insulin infusions to determine a patient's insulin needs before discharge from the hospital. Blood sugar control for type 2 diabetics that are inpatient or outpatient would improve as a result, with potentially far reaching public health benefits.
Interventions
- OTHER IICE Dosing
- OTHER Healthcare Provider dosing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00645827
The ClinicalTrials.gov registry entry for NCT00645827 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IICE Dosing is the first listed.
NCT00645827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00645827 about?
NCT00645827 is a clinical study titled "Use of an Insulin Infusion Conversion Equation (IICE) to Control Blood Glucose in Hospitalized Patients". Insulin infusions are commonly used in hospitalized diabetics to control blood sugar, and they are effective. However, insulin infusions require the use of limited resources. Insulin infusions are therefore changed to insulin shots as a patient recovers. Once an insulin infusion is stopped and shots...
What is the current status of trial NCT00645827?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2008-01. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00645827?
The interventions under investigation include: IICE Dosing (OTHER), Healthcare Provider dosing (OTHER).
Who is sponsoring clinical trial NCT00645827?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.